Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.40%38.8B | -7.68%34.22B | -9.54%9.15B | -13.31%8.08B | -8.28%8.46B | 1.49%8.53B | 14.58%37.06B | 12.45%10.11B | 12.12%9.33B | 20.30%9.22B |
| Cost of revenue | 14.69%30.21B | -6.03%26.34B | -9.61%7.01B | -8.66%6.35B | -6.31%6.39B | 1.30%6.6B | 15.30%28.04B | 17.25%7.75B | 11.79%6.95B | 17.81%6.82B |
| Gross profit | 9.09%8.59B | -12.77%7.87B | -9.32%2.14B | -26.92%1.74B | -13.89%2.07B | 2.14%1.93B | 12.42%9.03B | -0.91%2.36B | 13.13%2.38B | 27.95%2.41B |
| Operating expense | 7.10%5.72B | -8.26%5.34B | -12.25%1.42B | -10.86%1.29B | -8.26%1.25B | -1.00%1.39B | 10.11%5.82B | 8.79%1.61B | 1.82%1.44B | 7.32%1.36B |
| Selling and administrative expenses | 7.03%5.74B | -8.34%5.37B | -12.22%1.42B | -11.29%1.29B | -8.18%1.26B | -0.94%1.39B | 9.56%5.85B | 6.38%1.62B | 2.77%1.46B | 7.12%1.37B |
| -General and administrative expense | 7.03%5.74B | -8.34%5.37B | -12.22%1.42B | -11.29%1.29B | -8.18%1.26B | -0.94%1.39B | 9.56%5.85B | 6.38%1.62B | 2.77%1.46B | 7.12%1.37B |
| Other operating expenses | 155.34%29.86M | 517.53%11.7M | 326.86%5.8M | ---- | 2,925.00%4.36M | 458.08%1.86M | -90.22%1.89M | -69.80%1.36M | -99.61%57K | 44.00%144K |
| Total other operating income | 41.44%54.92M | 7.69%38.83M | 55.81%11.64M | -54.02%6.83M | 54.72%13.09M | 44.02%7.6M | -53.31%36.06M | -82.96%7.47M | -6.69%14.85M | -17.32%8.46M |
| Operating profit | 13.28%2.87B | -20.96%2.54B | -2.95%720.63M | -51.77%450.1M | -21.23%822.51M | 11.14%542.37M | 16.87%3.21B | -17.00%742.53M | 36.59%933.24M | 70.74%1.04B |
| Net non-operating interest income (expenses) | 78.61%67.22M | 314.49%37.64M | -41.32%5.44M | 487.31%22.75M | 16.73%-3.43M | 176.54%12.88M | -184.25%-17.55M | 145.16%9.27M | -154.55%-5.87M | -171.87%-4.12M |
| Non-operating interest income | 74.76%113.15M | 22.73%64.74M | -1.22%11.6M | --27.27M | -86.85%3.48M | 53.98%22.39M | -20.72%52.75M | 293.76%11.74M | ---- | 93.14%26.48M |
| Non-operating interest expense | 69.43%45.92M | -61.44%27.1M | 149.37%6.16M | -22.92%4.53M | -77.42%6.91M | -69.68%9.51M | 53.79%70.3M | -82.94%2.47M | -68.53%5.87M | 283.42%30.6M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 369.20%411.91M | -399.71%-153.01M | 102.95%31.11M | 384.70%63.37M | 420.64%66.54M | -3,282.00%-314.03M | 94.21%51.05M | 20.30%15.33M | 114.24%13.07M | -7.09%12.78M |
| Special income (charges) | 0 | 18.15B | 0 | 18.15B | 0 | 0 | ||||
| Less:Other special charges | ---- | ---18.15B | --0 | ---- | ---- | ---18.15B | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -83.71%3.35B | 534.73%20.57B | -1.30%757.18M | -42.98%536.21M | -15.88%885.62M | 3,724.13%18.4B | 16.09%3.24B | -13.49%767.13M | 34.33%940.44M | 66.84%1.05B |
| Income tax | -86.88%841.34M | 445.82%6.41B | -63.20%83.71M | -34.21%200.21M | -13.01%391.94M | 2,879.54%5.74B | 21.86%1.17B | -29.14%227.46M | 33.47%304.32M | 127.65%450.57M |
| Net income | -82.27%2.51B | 585.29%14.16B | 24.79%673.47M | -47.18%336M | -18.03%493.68M | 4,287.83%12.66B | 13.05%2.07B | -4.61%539.67M | 34.74%636.12M | 39.05%602.24M |
| Net income continuous operations | -82.27%2.51B | 585.29%14.16B | 24.79%673.47M | -47.18%336M | -18.03%493.68M | 4,287.83%12.66B | 13.05%2.07B | -4.61%539.67M | 34.74%636.12M | 39.05%602.24M |
| Noncontrolling interests | 95.67%40.89M | -90.84%20.9M | -99.95%35K | -88.94%6.99M | -85.11%8.93M | -86.54%4.94M | 391.96%228.05M | 800.50%68.2M | 5,766.20%63.18M | 160.54%59.98M |
| Net income attributable to the company | -82.54%2.47B | 669.15%14.14B | 42.84%673.44M | -42.57%329.01M | -10.61%484.75M | 4,925.13%12.65B | 3.19%1.84B | -15.54%471.46M | 21.64%572.94M | 32.23%542.26M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -82.54%2.47B | 669.15%14.14B | 42.84%673.44M | -42.57%329.01M | -10.61%484.75M | 4,925.13%12.65B | 3.19%1.84B | -15.54%471.46M | 21.64%572.94M | 32.23%542.26M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -82.48%214.51 | 687.78%1.22K | 41.16%57.44 | -41.02%28.44 | -7.35%41.97 | 5,104.78%1.1K | 3.48%155.38 | -13.31%40.69 | 21.68%48.22 | 31.00%45.3 |
| Diluted earnings per share | -82.48%214.45 | 691.22%1.22K | 41.16%57.44 | -40.44%28.4 | -5.46%41.87 | 5,262.15%1.1K | 4.84%154.69 | -12.59%40.69 | 22.60%47.68 | 31.27%44.29 |
| Dividend per share | 4.00%78 | 56.25%75 | 50.00%39 | 0 | 63.64%36 | 0 | 6.67%48 | -10.34%26 | 0 | 37.50%22 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |